Angiomyolipoma with epithelial cysts (AMLEC): a rare but distinct variant of angiomyolipoma
© Armah et al; licensee BioMed Central Ltd. 2007
Received: 08 March 2007
Accepted: 21 March 2007
Published: 21 March 2007
Angiomyolipoma with epithelial cysts (AMLEC) is a recently described distinct cystic variant of angiomyolipoma (AML). To date 15 cases of AMLEC have been reported in 2 case series. We report the 16th case in a 39-year-old female. Her left kidney tumor was discovered incidentally. Partial nephrectomy was performed. Histologically, the tumor was composed of three components: 1) epithelial cysts lined by cuboidal to hobnail cells; 2) compact subepithelial mullerian-like AML stroma with admixed chronic inflammation; and 3) muscle-predominant AML with dysmorphic blood vessels exterior to the subepithelial stroma. Immunohistochemically, the subepithelial stroma stained most intensely with HMB-45 and Melan-A, whilst the muscle-predominant AML areas stained most intensely with smooth muscle actin and desmin. Estrogen receptor (ER), progesterone receptor (PR), and CD10 stained most intensely in the subepithelial stroma. The cyst lining was positive for pancytokeratin, but negative for HMB-45, Melan-A, ER, PR, and CD10. The patient is alive with no evidence of disease, 12 months postoperatively, and yearly follow-up CT scans are planned.
Angiomyolipomas (AMLs) are well-characterized triphasic tumors composed of varying amounts of vascular (thick-walled dysplastic or dysmorphic blood vessels), smooth muscle (spindled or epithelioid with clear cytoplasm) and mature adipose elements . AML usually occurs in the kidney, but can occasionally involve the liver and retroperitoneum. AML comprise 2.0–6.4% of all renal tumors, however they represent one of the most common benign renal lesions . AML can occur as an isolated renal lesion or as part of the tuberous sclerosis complex (TSC). Approximately 50% of patients with TSC develop AML, which tend to be bilateral and multifocal . The triphasic nature of AML has led many in the past to consider these lesions as hamartomatous. However, recent detection of clonal genomic alterations [3–5] and rare case reports of malignancy in AMLs [1, 6–8] favor their classification as neoplastic lesions. AMLs share morphologic and immunohistological features with perivascular epithelioid cell (PEC), and are considered to be among the growing family of tumors derived from these distinctive cells, also referred to as PEComas, and that includes clear cell ("sugar") tumors of the lung and pancreas, and lymphangioleiomyomatosis [9, 10]. Although the diagnosis of AML is usually straightforward, some cases showing predominance of any one of the AML components may mimic a number of lesions and lead to an erroneous diagnosis of malignancy, including liposarcoma (fat-predominant AML), leiomyoma (muscle-predominant AML), renal cell carcinoma (epithelioid AML), and vascular malformations (paucicellular, vascular-predominant AML) . The evolution of AML is classically benign, but malignant transformation has been rarely reported in 12 cases to date [1, 6–8].
AMLs are typically solid lesions both radiologically and grossly , without cystic or epithelial components. Although entrapped non-cystic renal tubules have been described in AML, presentation as a cystic mass has been reported recently in only 15 cases in two case series [11, 12]. This distinctive benign renal neoplasm has recently been recognized and termed angiomyolipoma with epithelial cysts (AMLEC) by Fine and colleagues  or cystic angiomyolipoma by Davis and colleagues . These descriptive names for this entity are currently favored until its pathogenesis and relationships to other renal neoplasms are better understood. Therefore, AMLEC or cystic AML has to be considered in the differential diagnosis of adult cystic renal neoplasms, which includes cystic renal cell carcinomas, cystic nephroma (CN), and mixed epithelial and stromal tumor (MEST). The most distinctive immunohistochemical feature of AMLEC or cystic AML, absent in the above three tumors mentioned earlier is immunoreactivity with melanocytic markers (HMB45 and Melan-A) [11, 12]. We report herein one more case of AMLEC or cystic AML in a 39-year-old female.
A 39-year-old woman had a left kidney tumor incidentally discovered during CT scan as part of a diagnostic workup for colonic diverticulosis. She had no personal or family history of TSC, lymphangioleiomyomatosis, renal cyst, renal malignancy, or estrogen hormonal therapy. The CT scan revealed a 2.5-cm complex cystic mass in the upper pole of the left kidney with a 1-cm enhancing nodule in its wall, radiologically worrisome for cystic renal cell carcinoma. In view of this concern of malignancy, the patient elected to undergo laparoscopic left partial nephrectomy for definitive surgical treatment. The entire tumor was surgically resected with an excellent margin of 5-mm of normal parenchyma surrounding the entire cyst wall, and the tumor was confined to the kidney.
The renal tumor herein presented was histologically and immunophenotypically diagnostic of muscle-predominant AML containing prominent and grossly evident epithelial cysts. This phenotype is distinctly unusual, as AMLs are typically solid , and reminiscent of the recently described distinct cystic variant of AML that has been seperately designated as cystic AML or AMLEC [11, 12]. It is well known that AMLs occur both in association with TSC and sporadically . Bilateral or multiple AMLs have been considered presumptive evidence of, or diagnostic of, TSC . The case herein presented had no personal or family history of TSC. From the 15 previously reported [11, 12] and our case of AMLEC, only 1 out of these 16 cases of AMLEC was associated with TSC, suggesting that this rare variant of AML may not be related to TSC. Additionally, the female/male ratio is 10/6 for these 16 cases of AMLEC, indicating a slight female predominance for AMLEC. Therefore, unlike MEST which is considered estrogen hormone dependent because of its almost exclusive occurrence in females, AMLEC may be estrogen hormone independent. AMLs have been considered benign lesions and those found in the kidney are generally managed conservatively. Partial nephrectomy or angiographic embolization has been recommended for symptomatic lesions and lesions greater than 4-cm, and most asymptomatic lesions are followed with interval abdominal imaging . However, 12 cases of metastatic AML have been reported [1, 6–8]. Though the asymptomatic cystic renal tumor in the case herein presented was less than 4-cm in greatest dimension, definitive surgical treatment was pursued because of the presence of a radiologically enhancing nodule in the cyst wall, which was worrisome for malignancy.
AMLEC are readily distinct from most adult cystic renal lesions. The chief differential diagnostic consideration for AMLEC or cystic AML is mixed epithelial and stromal tumor (MEST), previously classified as cystic hamartomas of the renal pelvis, adult mesoblastic nephroma, or renal pelvic or cortical hamartomas [11, 12]. Immunohistochemically, the stroma of both AMLEC and MEST labels for smooth muscle actin, desmin, ER, and PR [11, 12]. However, the most distinctive immunohistochemical feature of AMLEC or cystic AML, absent in all the differential diagnostic considerations mentioned above, is immunostaining with melanocytic markers (HMB45 and Melan-A) [11, 12], as noted in our case. This study further expands on the immunophenotype of this new histologic entity by reporting for the first time that AMLEC shows absence of immunoreactivity for WT-1, c-kit and CK20. The other important benign differential diagnostic consideration for AMLEC or cystic AML is cystic nephroma (CN). The main malignant differential diagnostic consideration for AMLEC or cystic AML is multilocular cystic renal cell carcinoma. Based on the results of immunohistochemical staining in the case herein presented, cystic and sarcomatous renal cell carcinoma (HMB45 negative), cystic nephroma (HMB45 negative), mixed epithelial and stromal tumor (HMB45 negative), leiomyosarcoma (HMB45 negative), and melanoma (HMB45 positive, S-100 protein positive) were excluded as differential diagnoses. The presence of HMB45 in PEC of AML has been widely recognized as a specific finding, however, that of c-kit (CD117) has not been as common [4, 6, 9]. According to recent reports, c-kit is also expressed in renal oncocytoma (71%), chromophobic renal cell carcinoma (85%) and even in PEC in classic AML [14, 15]. The case we describe was not immunoreactive for c-kit.
The histogenesis of AMLEC or cystic AML is unclear. However, the histogenesis of the mullerian-like stroma in AMLEC has been postulated to be due to the embryological proximity between the urinary and genital systems . These two systems share common origin from the urogenital ridge, and it has been postulated that disturbances during a critical period in development may lead to crossover of epithelium or mesenchymal elements between the two systems, predisposing to neoplasms that combine these features . The strong HMB-45 positivity of the "cambium-like" layer of compact subepithelial cells in AMLEC supports the concept that they are a variant of AML, although their morphology is distinctly different from the exterior muscle-predominant AML wall. The mullerian histomorphology and peculiar immunohistochemical profile (HMB45+, Melan-A+, ER+, PR+, and CD10+) of the compact subepithelial cells suggests both mullerian and melanocytic differentiation of PECs in AMLEC, a rare variant of AML . This observation of dual differentiation is not unprecedented in AML, since the smooth muscle cells of AMLs are known to have both melanocytic and muscular features [1, 4, 6, 9]. The minimal immunoreactivity for muscle markers in this subepithelial zone suggests that these cells have lost some of their muscular phenotype while developing a mullerian phenotype. Apart from the fact that the presence of epithelium is extremely uncommon in AML and has been reported previously in only 15 cases [11, 12], the nature of the epithelium within AMLEC is also controversial. Davis and colleagues  favored the view that the epithelial component of AMLEC represented true epithelial differentiation by the AML, whilst Fine and colleagues  favored the view that it mainly represented dilated entrapped native renal collecting duct epithelium. Both views are plausible.
AMLEC should be routinely included in the differential diagnostic considerations for adult cystic renal neoplasms, which includes cystic renal cell carcinomas, cystic nephroma (CN), and mixed epithelial and stromal tumor (MEST). Although, AMLEC may be confused with MEST, the most distinctive feature is the fact that AMLEC is immunoreactive to melanocytic markers (HMB45 and Melan-A).
- L'Hostis H, Deminiere C, Ferriere JM, Coindre JM: Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol. 1999, 23 (9): 1011-1020. 10.1097/00000478-199909000-00003.View ArticlePubMed
- Neumann HP, Schwarzkopf G, Henske EP: Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol. 1998, 5 (4): 269-275. 10.1016/S1071-9091(98)80005-3.View ArticlePubMed
- Green AJ, Sepp T, Yates JR: Clonality of tuberous sclerosis harmatomas shown by non-random X-chromosome inactivation. Hum Genet. 1996, 97 (2): 240-243. 10.1007/BF02265273.View ArticlePubMed
- Martignoni G, Pea M, Bonetti F, Zamboni G, Carbonara C, Longa L, Zancanaro C, Maran M, Brisigotti M, Mariuzzi GM: Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study. Am J Surg Pathol. 1998, 22 (6): 663-672. 10.1097/00000478-199806000-00003.View ArticlePubMed
- Kattar MM, Grignon DJ, Eble JN, Hurley PM, Lewis PE, Sakr WE, Cher ML: Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: evidence for clonal origin. Hum Pathol. 1999, 30 (3): 295-299. 10.1016/S0046-8177(99)90008-4.View ArticlePubMed
- Cibas ES, Goss GA, Kulke MH, Demetri GD, Fletcher CD: Malignant epithelioid angiomyolipoma ('sarcoma ex angiomyolipoma') of the kidney: a case report and review of the literature. Am J Surg Pathol. 2001, 25 (1): 121-126. 10.1097/00000478-200101000-00014.View ArticlePubMed
- Martignoni G, Pea M, Rigaud G, Manfrin E, Colato C, Zamboni G, Scarpa A, Tardanico R, Roncalli M, Bonetti F: Renal angiomyolipoma with epithelioid sarcomatous transformation and metastases: demonstration of the same genetic defects in the primary and metastatic lesions. Am J Surg Pathol. 2000, 24 (6): 889-894. 10.1097/00000478-200006000-00017.View ArticlePubMed
- Park HK, Zhang S, Wong MK, Kim HL: Clinical presentation of epithelioid angiomyolipoma. Int J Urol. 2007, 14 (1): 21-25. 10.1111/j.1442-2042.2006.01665.x.View ArticlePubMed
- Bonetti F, Pea M, Martignoni G, Doglioni C, Zamboni G, Capelli P, Rimondi P, Andrion A: Clear cell ("sugar") tumor of the lung is a lesion strictly related to angiomyolipoma--the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology. 1994, 26 (3): 230-236. 10.1080/00313029400169561.View ArticlePubMed
- Zamboni G, Pea M, Martignoni G, Zancanaro C, Faccioli G, Gilioli E, Pederzoli P, Bonetti F: Clear cell "sugar" tumor of the pancreas. A novel member of the family of lesions characterized by the presence of perivascular epithelioid cells. Am J Surg Pathol. 1996, 20 (6): 722-730. 10.1097/00000478-199606000-00010.View ArticlePubMed
- Fine SW, Reuter VE, Epstein JI, Argani P: Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol. 2006, 30 (5): 593-599. 10.1097/01.pas.0000194298.19839.b4.View ArticlePubMed
- Davis CJ, Barton JH, Sesterhenn IA: Cystic angiomyolipoma of the kidney: a clinicopathologic description of 11 cases. Mod Pathol. 2006, 19 (5): 669-674. 10.1038/modpathol.3800572.View ArticlePubMed
- Steiner MS, Goldman SM, Fishman EK, Marshall FF: The natural history of renal angiomyolipoma. J Urol. 1993, 150 (6): 1782-1786.PubMed
- Makhlouf HR, Remotti HE, Ishak KG: Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002, 26 (4): 493-497. 10.1097/00000478-200204000-00012.View ArticlePubMed
- Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C: KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am J Surg Pathol. 2004, 28 (5): 676-678.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.